Affinity Profiling of the Cellular Kinome for the Nucleotide Cofactors ATP, ADP, and GTP

被引:66
作者
Becher, Isabelle [1 ]
Savitski, Mikhail M. [1 ]
Savitski, Maria Faelth [1 ]
Hopf, Carsten [1 ]
Bantscheff, Marcus [1 ]
Drewes, Gerard [1 ]
机构
[1] Cellzome GmbH, D-69117 Heidelberg, Germany
关键词
PROTEIN-KINASE INHIBITORS; ABSOLUTE QUANTIFICATION; CHEMICAL PROTEOMICS; TARGETING CANCER; DRUG DISCOVERY; SELECTIVITY; CELLS; ACQUISITION; FEATURES; UPDATE;
D O I
10.1021/cb3005879
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Most kinase inhibitor drugs target the binding site of the nucleotide cosubstrate ATP. The high intracellular concentration of ATP can strongly affect inhibitor potency and selectivity depending on the affinity of the target kinase for ATP. Here we used a defined chemoproteomics system based on competition-binding assays in cell extracts from Jurkat and SK-MEL-28 cells with immobilized ATP mimetics (kinobeads). This system enabled us to assess the affinities of more than 200 kinases for the cellular nucleotide cofactors ATP, ADP, and GTP and the effects of the divalent metal ions Mg2+ and Mn2+. The affinity values determined in this system were largely consistent across the two cell lines, indicating no major dependence on kinase expression levels. Kinase-ATP affinities range from low micromolar to millimolar, which has profound consequences for the prediction of cellular effects from inhibitor selectivity profiles. Only a small number of kinases including CK2, MEK, and BRAF exhibited affinity for GTP. This extensive and consistent data set of kinase-nucleotide affinities, determined for native enzymes under defined experimental conditions, will represent a useful resource for kinase drug discovery.
引用
收藏
页码:599 / 607
页数:9
相关论文
共 41 条
[1]   Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity [J].
Anastassiadis, Theonie ;
Deacon, Sean W. ;
Devarajan, Karthik ;
Ma, Haiching ;
Peterson, Jeffrey R. .
NATURE BIOTECHNOLOGY, 2011, 29 (11) :1039-U117
[2]   The specificities of protein kinase inhibitors: an update [J].
Bain, J ;
McLauchlan, H ;
Elliott, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2003, 371 :199-204
[3]   The selectivity of protein kinase inhibitors: a further update [J].
Bain, Jenny ;
Plater, Lorna ;
Elliott, Matt ;
Shpiro, Natalia ;
Hastie, C. James ;
Mclauchlan, Hilary ;
Klevernic, Iva ;
Arthur, J. Simon C. ;
Alessi, Dario R. ;
Cohen, Philip .
BIOCHEMICAL JOURNAL, 2007, 408 :297-315
[4]   Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors [J].
Bantscheff, Marcus ;
Eberhard, Dirk ;
Abraham, Yann ;
Bastuck, Sonja ;
Boesche, Markus ;
Hobson, Scott ;
Mathieson, Toby ;
Perrin, Jessica ;
Raida, Manfred ;
Rau, Christina ;
Reader, Valerie ;
Sweetman, Gavain ;
Bauer, Andreas ;
Bouwmeester, Tewis ;
Hopf, Carsten ;
Kruse, Ulrich ;
Neubauer, Gitte ;
Ramsden, Nigel ;
Rick, Jens ;
Kuster, Bernhard ;
Drewes, Gerard .
NATURE BIOTECHNOLOGY, 2007, 25 (09) :1035-1044
[5]   Chemoproteomic approaches to drug target identification and drug profiling [J].
Bantscheff, Marcus ;
Drewes, Gerard .
BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (06) :1973-1978
[6]   Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes [J].
Bantscheff, Marcus ;
Hopf, Carsten ;
Savitski, Mikhail M. ;
Dittmann, Antje ;
Grandi, Paola ;
Michon, Anne-Marie ;
Schlegl, Judith ;
Abraham, Yann ;
Becher, Isabelle ;
Bergamini, Giovanna ;
Boesche, Markus ;
Delling, Manja ;
Duempelfeld, Birgit ;
Eberhard, Dirk ;
Huthmacher, Carola ;
Mathieson, Toby ;
Poeckel, Daniel ;
Reader, Valerie ;
Strunk, Katja ;
Sweetman, Gavain ;
Kruse, Ulrich ;
Neubauer, Gitte ;
Ramsden, Nigel G. ;
Drewes, Gerard .
NATURE BIOTECHNOLOGY, 2011, 29 (03) :255-U124
[7]  
Bergamini G, 2012, NAT CHEM BIOL, V8, P576, DOI [10.1038/nchembio.957, 10.1038/NCHEMBIO.957]
[8]   Proteomics Analysis of Cellular Imatinib Targets and their Candidate Downstream Effectors [J].
Breitkopf, Susanne B. ;
Oppermann, Felix S. ;
Keri, Gyoergy ;
Grammel, Markus ;
Daub, Henrik .
JOURNAL OF PROTEOME RESEARCH, 2010, 9 (11) :6033-6043
[9]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[10]   Protein kinases - the major drug targets of the twenty-first century? [J].
Cohen, P .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :309-315